Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion | Reuters.com
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Israeli unions warn Teva Pharm over plan to close Ashdod plant
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva Pharma to sell more women's health assets for $1.38 billion | Reuters
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals to Lay Off 14,000 People
Teva leans on Ajovy and Austedo as revenues sink
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/32KWZMZCHJLHBO2426REAC4T2I.jpg "Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters")
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/EDAT5T7QVVOGZP6VRKJB4IAP5E.jpg "Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters")
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva generic medicines hi-res stock photography and images - Alamy
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Teva lied about opioid role, New York says | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
